Literature DB >> 732894

Chemotactic effects of the complement-derived peptides C3a, C3ai and C5a (classical anaphylatoxin) on rabbit and guinea-pig polymorphonuclear leukocytes.

B Damerau, E Grünefeld, W Vogt.   

Abstract

The complement-derived peptides C3a, C3ai and C5a (= classical anaphylatoxin) were purified from hog serum and examined for chemotactic activity on rabbit and guinea-pig polymorphonuclear leukocytes (PMN) with the Boyden chamber technique (with filters of 3,0 micrometer pore size). When media containing albumin or serum were used all peptides induced chemotaxis of both cell species. Only C3a showed a pronounced species dependence in that it was much more active on rabbit than on guinea-pig PMN. No gross differences were found between the influence of 0.5% BSA and 10% heated (56 degree, 30 min) homologous serum added to the medium. In the absence of protein chemotaxis did not occur.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 732894     DOI: 10.1007/bf00508290

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  21 in total

1.  Relation between stimulus intensity and neutrophil chemotactic response.

Authors:  H U Keller; J H Wissler; M W Hess; H Cottier
Journal:  Experientia       Date:  1977-04-15

2.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

3.  [Effect of anaphylatoxin (AT) upon capillary permeability in guinea pig skin].

Authors:  G Bodammer; W Vogt
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

4.  A neutrophil chemotactic factor from human C'5.

Authors:  P A Ward; L J Newman
Journal:  J Immunol       Date:  1969-01       Impact factor: 5.422

5.  Complement-derived leukotactic factors in inflammatory synovial fluids of humans.

Authors:  P A Ward; N J Zvaifler
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

6.  Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.

Authors:  W Dias Da Silva; I H Lepow
Journal:  J Exp Med       Date:  1967-05-01       Impact factor: 14.307

7.  Complement-derived leukotactic factors in pathological fluids.

Authors:  P A Ward
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

8.  The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.

Authors:  C G Cochrane; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-02-01       Impact factor: 14.307

9.  The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats.

Authors:  J H Hill; P A Ward
Journal:  J Exp Med       Date:  1971-04-01       Impact factor: 14.307

10.  Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.

Authors:  V A Bokisch; H J Müller-Eberhard; C G Cochrane
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

View more
  2 in total

1.  Retinal and nonocular abnormalities in Cyp27a1(-/-)Cyp46a1(-/-) mice with dysfunctional metabolism of cholesterol.

Authors:  Aicha Saadane; Natalia Mast; Casey D Charvet; Saida Omarova; Wenchao Zheng; Suber S Huang; Timothy S Kern; Neal S Peachey; Irina A Pikuleva
Journal:  Am J Pathol       Date:  2014-07-25       Impact factor: 4.307

2.  Complement-derived polypeptide C3adesArg as a mediator of inflammation at the blood-brain barrier in a new experimental cat model.

Authors:  H G Höllerhage; G F Walter; D Stolke
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.